Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes
- نوع فایل : کتاب
- زبان : انگلیسی
- مؤلف : Madhura S. Mehta Alexei Vazquez Diptee A. Kulkarni John E. Kerrigan Gurinder Atwal Shoichi Metsugi Deborah L. Toppmeyer Arnold J. Levine
- چاپ و سال / کشور: 2010
Description
TSC1 acts coordinately with TSC2 in a complex to inhibit mTOR, an emerging therapeutic target and known promoter of cell growth and cell cycle progression. Perturbation of the mTOR pathway, through abnormal expression or function of pathway genes, could lead to tumorigenesis. TSC1 and TSC2 expression is reduced in invasive breast cancer as compared with normal mammary epithelium. Because single nucleotide polymorphisms (SNPs) in regulatory genes have been implicated in risk and age at diagnosis of breast cancers, systematic SNP association studies were performed on TSC1 and TSC2 SNPs for their associations with clinical features of breast cancer. TSC1 and TSC2 haplotypes were constructed from genotyping of multiple loci in both genes in healthy volunteers. SNPs were selected for further study using a bioinformatics approach based on SNP associations with drug response in NCI-60 cell lines and evidence of selection bias based on haplotype frequencies. Genotyping for five TSC1 and one TSC2 loci were performed on genomic DNA from 1,137 women with breast cancer. This study found that for TSC1 rs7874234, TT variant carriers had a 9-year later age at diagnosis of estrogen receptor positive (ER?), but not ER-, ductal carcinomas (P = 0.0049). No other SNP locus showed an association with age at diagnosis, nor any other breast cancer phenotype. TSC1 rs7874234 is hypothesized to be functional in ER? breast cancer because the T allele, but not the C allele, may create an estrogen receptor element (ERE) site, resulting in increased TSC1 transcription and subsequent inhibition of mTOR.
Breast Cancer Res Treat (2011) 125:861–868 DOI 10.1007/s10549-010-1062-1 Received: 28 May 2010 / Accepted: 9 July 2010 / Published online: 25 July 2010
